Update on the evaluation and management of dysphagia in sporadic inclusion body myositis.
Journal
Current opinion in otolaryngology & head and neck surgery
ISSN: 1531-6998
Titre abrégé: Curr Opin Otolaryngol Head Neck Surg
Pays: United States
ID NLM: 9417024
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
medline:
3
11
2023
pubmed:
8
9
2023
entrez:
7
9
2023
Statut:
ppublish
Résumé
Dysphagia is a common symptom of sporadic inclusion body myositis (IBM), affecting disease trajectory and patient quality-of-life. Despite this, it is considerably understudied. The purpose of this review is to summarize current evidence related to the evaluation and management of dysphagia in IBM. We highlight a patient case involving a multidisciplinary management approach, and we encourage continued exploration of exercises for delaying progression and improving impairments in patients with IBM and dysphagia. Recent investigations confirm that dysphagia in IBM is a debilitating and complex symptom that warrants timely evaluation and management. Further, they highlight the lack of validation of standardized swallowing-related metrics specifically for IBM and the limited evidence supporting a consensus of management approaches. Small scale research and clinical anecdotal data support a multidisciplinary and multipronged patient-centered approach, including rehabilitative exercise protocols, for dysphagia management in IBM. A paucity exists in the literature to effectively guide clinical decision-making for patients with IBM and dysphagia. Given this, it is our belief that a careful multidisciplinary and multipronged patient-centered approach is critical for dysphagia management in IBM. Prospective, longitudinal research on the underlying mechanisms of swallowing dysfunction using advanced and validated swallowing-related outcome measures is urgently needed.
Identifiants
pubmed: 37678324
doi: 10.1097/MOO.0000000000000922
pii: 00020840-990000000-00081
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
362-367Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Dimachkie MM, Barohn RJ. Inclusion body myositis. Neurol Clin 2014; 32:629–646.
Greenberg SA. Inclusion body myositis: clinical features and pathogenesis. Nature Rev Rheumatol 2019; 15:257–272.
Labiet B, Pawlitzki M, Ruck T, et al. The impact of dysphagia in myositis: a systematic review and meta-analysis. J Clin Med 2020; 9:2150.
Ambrocio KR, (Focht) Garand KL, Roy B, et al. Diagnosing and managing dysphagia in inclusion body myositis: a systematic review. Rheumatol 2023; https://doi.org/10.1093/rheumatology/kead194 .
Mohannak N, Pattison G, Hird K, Needham M. Dysphagia in patients with sporadic inclusion body myositis: management challenges. Inter J Gen Med 2019; 12:465–474.
Dimachkie MM, Barohn RJ. Inclusion body myositis. Curr Neurol Neurosci Rep 2013; 13:321.
Zeng R, Schmidt J. Impact and management of dysphagia in inflammatory myopathies. Current Rheumatol Rep 2020; 22:74.
Naddaf E. Inclusion body myositis: update on the diagnostic and therapeutic landscape. Front Neurol eCollection 2022; 13:1020113.
Alfano LN, (Focht) Garand KL, Malandraki GA, et al. Measuring change in inclusion body myositis: clinical assessments versus imaging. Clin Exp Rheumatol 2022; 40:404–413.
Belafsky PC, Mouadeb DA, Rees CJ, et al. Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol 2008; 117:919–924.
Jackson CE, Barohn RJ, Gronseth G, et al. Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve 2008; 37:473–476.
Roy B, Lucchini M, Lillekar JB, et al. Current status of clinical outcome measures in inclusion body myositis; a systematised review. Clin Exp Rheumatol 2023; 41:370–378.
Ramdharry G, Morrow J, Hudgens S, et al. Investigation of the psychometric properties of the inclusion body myositis functional rating scale with Rasch analysis. Muscle Nerve 2019; 60:161–168.
Silbergleit AK, Schultz L, Jacobson BH, et al. The Dysphagia Handcap Index: development and validation. Dysphagia 2012; 27:45–52.
Belafksy PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002; 16:274–277.
Brady S, Donzelli J. The modified barium swallow and the functional endoscopic evaluation of swallowing. Otolaryngol Clin North Am 2013; 46:1009–1022.
Pisegna JM, Langmore SE. Parameters of instrumental swallowing evaluations: describing a diagnostic dilemma. Dysphagia 2016; 31:462–472.
Chiba T. Inclusion body myositis with dysphagia diagnosed with pharyngoesophageal high-resolution manometry. ACG Case Rep J 2022; 9:e00850.
Olthoff A, Carstens PO, Zhang S, et al. Evaluation of dysphagia by novel real-time MRI. Neurology 2016; 87:2132–2138.
Rose MR, Jones K, Leong K, et al. Treatment for inclusion body myositis. Cochrane Database Syst Rev 2015; 7:CD001555.
Dalakas MC. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology 1998; 51: (Suppl 5): S37–S45.
Taira K, Yamamoto T, Mori-Yoshimura M, et al. Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis. J Neurol 2021; 268:1016–1024.
Mohannak N, Pattison G, Radich B, et al. Exploring the efficacy of the expiratory muscle strength trainer to improve swallowing in inclusion body myositis: a pilot study. Neuromuscul Disord 2020; 30:294–300.
Garand KL, Beall J, Hill EG, et al. Effects of presbyphagia on oropharyngeal swallowing observed during modified bariums wallow studies. J Nutr Health Aging 2022; 26:973–980.
Benlidayi IC, Gupta L. The pathophysiological effects of exercise in the management of idiopathic inflammatory myopathies: a scoping review. Int J Rehum Dis 2021; 21:896–903.
Oh TH, Brumfield KA, Hoskin TL, et al. Dysphagia in inclusion body myositis. Am J Phys Med Rehabil 2008; 87:883–889.
Malandraki GA, Kauffman A, Hind J, et al. The effects of lingual intervention in a patient with Inclusion Body Myositis and Sjögren's syndrome: a longitudinal case study. Arch Phys Med Rehab 2012; 93:1469–1475.
Singh H, Nene Y, Mehta TR, Govindarajan R. Efficacy of botulinum toxin for treating sialorrhea in neuromuscular conditions. Front Neurol 2020; 11:513.
Witting N, Daugaard D, Prytz S, et al. Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositis. J Neurol 2022; 269:4154–4160.
Malandraki GA, Rajappa A, Kantarcigil C, et al. The Intensive Dysphagia Rehabilitation Approach (IDRA) for neurogenic dysphagia: a case-series design. Arch Phys Med Rehab 2016; 97:567–574.